Hood River Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-131,846
| Closed | -$8.37M | – | 117 |
|
|
2019
Q2 | $8.37M | Buy |
131,846
+4,765
| +4% | +$303K | 0.39% | 83 |
|
|
2019
Q1 | $8.81M | Sell |
127,081
-5,385
| -4% | -$373K | 0.44% | 84 |
|
|
2018
Q4 | $5.76M | Buy |
132,466
+1,903
| +1% | +$82.7K | 0.34% | 85 |
|
|
2018
Q3 | $9.97M | Sell |
130,563
-816
| -0.6% | -$62.3K | 0.44% | 82 |
|
|
2018
Q2 | $10.1M | Buy |
131,379
+5,149
| +4% | +$396K | 0.52% | 80 |
|
|
2018
Q1 | $6.44M | Buy |
126,230
+3,039
| +2% | +$155K | 0.36% | 84 |
|
|
2017
Q4 | $5.71M | Buy |
123,191
+8,897
| +8% | +$413K | 0.33% | 81 |
|
|
2017
Q3 | $6.09M | Buy |
114,294
+1,998
| +2% | +$106K | 0.39% | 81 |
|
|
2017
Q2 | $6.98M | Buy |
112,296
+2,667
| +2% | +$166K | 0.48% | 75 |
|
|
2017
Q1 | $7.43M | Sell |
109,629
-48,761
| -31% | -$3.31M | 0.56% | 74 |
|
|
2016
Q4 | $11.1M | Buy |
158,390
+48,099
| +44% | +$3.38M | 0.97% | 42 |
|
|
2016
Q3 | $7.82M | Buy |
+110,291
| New | +$7.82M | 0.8% | 57 |
|